» Articles » PMID: 33849249

Cumulative Exposure to Metabolic Syndrome Components and the Risk of Dementia: A Nationwide Population-Based Study

Overview
Specialty Endocrinology
Date 2021 Apr 14
PMID 33849249
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Metabolic disturbances are modifiable risk factors for dementia. Because the status of metabolic syndrome (MetS) and its components changes over time, we aimed to investigate the association of the cumulative exposure to MetS and its components with the risk of dementia.

Methods: Adults (n=1,492,776; ≥45-years-old) who received health examinations for 4 consecutive years were identified from a nationwide population-based cohort in Korea. Two exposure-weighted scores were calculated: cumulative number of MetS diagnoses (MetS exposure score, range of 0 to 4) and the composite of its five components (MetS component exposure score, range of 0 to 20). Hazard ratio (HR) and 95% confidence interval (CI) values for dementia were analyzed using the multivariable Cox proportional-hazards model.

Results: Overall, 47.1% of subjects were diagnosed with MetS at least once, and 11.5% had persistent MetS. During the mean 5.2 years of follow-up, there were 7,341 cases (0.5%) of incident dementia. There was a stepwise increase in the risk of all-cause dementia, Alzheimer's disease, and vascular dementia with increasing MetS exposure score and MetS component exposure score (each P for trend <0.0001). The HR of all-cause dementia was 2.62 (95% CI, 1.87 to 3.68) in subjects with a MetS component exposure score of 20 compared with those with a score of 0. People fulfilling only one MetS component out of 20 already had an approximately 40% increased risk of all-cause dementia and Alzheimer's disease.

Conclusion: More cumulative exposure to metabolic disturbances was associated with a higher risk of dementia. Of note, even minimal exposure to MetS components had a significant effect on the risk of dementia.

Citing Articles

Longitudinal Association of Changes in Metabolic Syndrome with Cognitive Function: 12-Year Follow-up of the Guangzhou Biobank Cohort Study.

Tian Y, Zhang W, Jiang C, Zhu F, Jin Y, Au Yeung S Diabetes Metab J. 2024; 49(1):60-79.

PMID: 39467662 PMC: 11788543. DOI: 10.4093/dmj.2024.0117.


Investigating the nexus of metabolic syndrome, serum uric acid, and dementia risk: a prospective cohort study.

Chen T, Mi N, Lao H, Wang C, Lo W, Mao Y BMC Med. 2024; 22(1):115.

PMID: 38481272 PMC: 10938845. DOI: 10.1186/s12916-024-03302-5.


Electroacupuncture stimulation improves cognitive ability and regulates metabolic disorders in Alzheimer's disease model mice: new insights from brown adipose tissue thermogenesis.

Li T, Tian J, Wu M, Tian Y, Li Z Front Endocrinol (Lausanne). 2024; 14:1330565.

PMID: 38283741 PMC: 10811084. DOI: 10.3389/fendo.2023.1330565.


Cumulative effect of impaired fasting glucose on the risk of dementia in middle-aged and elderly people: a nationwide cohort study.

Yu J, Lee K, Kim H, Han K, Lee S Sci Rep. 2023; 13(1):20600.

PMID: 37996487 PMC: 10667225. DOI: 10.1038/s41598-023-47566-y.


Is metabolic-healthy obesity associated with risk of dementia? An age-stratified analysis of the Whitehall II cohort study.

Machado-Fragua M, Sabia S, Fayosse A, Hassen C, van der Heide F, Kivimaki M BMC Med. 2023; 21(1):436.

PMID: 37957712 PMC: 10644649. DOI: 10.1186/s12916-023-03155-4.


References
1.
Borshchev Y, Uspensky Y, Galagudza M . Pathogenetic pathways of cognitive dysfunction and dementia in metabolic syndrome. Life Sci. 2019; 237:116932. DOI: 10.1016/j.lfs.2019.116932. View

2.
Kalmijn S, Foley D, White L, Burchfiel C, Curb J, Petrovitch H . Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler Thromb Vasc Biol. 2000; 20(10):2255-60. DOI: 10.1161/01.atv.20.10.2255. View

3.
Lee J, Shin D, Han K, Kim D, Yoo J, Lee J . Changes in Metabolic Syndrome Status and Risk of Dementia. J Clin Med. 2020; 9(1). PMC: 7019689. DOI: 10.3390/jcm9010122. View

4.
Ninomiya T, Ohara T, Hirakawa Y, Yoshida D, Doi Y, Hata J . Midlife and late-life blood pressure and dementia in Japanese elderly: the Hisayama study. Hypertension. 2011; 58(1):22-8. DOI: 10.1161/HYPERTENSIONAHA.110.163055. View

5.
Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson L, Nilsson L . 15-year longitudinal study of blood pressure and dementia. Lancet. 1996; 347(9009):1141-5. DOI: 10.1016/s0140-6736(96)90608-x. View